Tokyo Medical and Dental University Hospital
Bunkyo Ku, Japan
University hospital in Bunkyō, Tokyo
1 Chome-5-45 Yushima, Bunkyo City, Tokyo 113-8519
About Tokyo Medical and Dental University Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Eli Lilly and Company
13
Pfizer
8
Hoffmann-La Roche
7
Janssen Research & Development, LLC
7
Haruhiko Fukuda
5
Janssen Pharmaceutical K.K.
5
Takeda
5
Boehringer Ingelheim
4
Alexion
3
Galapagos NV
3
Gilead Sciences
3
Clinical Trials at Tokyo Medical and Dental University Hospital
During the past decade, Tokyo Medical and Dental University Hospital conducted 76 clinical trials. In the 10-year time frame, 76 clinical trials started and 27 clinical trials were completed, i.e. on
average, 35.5% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 16 clinical trials were completed. i.e. 47.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
GCSSG-SPNX: Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma: JCOG0110
2002-06-01
2014-03-01
Completed
500
A Trial to Evaluate Laparoscopic Versus Open Surgery for Colorectal Cancer
2004-11-01
2014-03-01
Completed
1,050
A Trial Comparing Adjuvant Oral UFT/LV to 5-FU/l-LV in Stage III Colorectal Cancer (JCOG-0205-MF)
2003-02-01
2011-11-01
Completed
1,101
Mesorectal Excision (ME) Versus ME With Lateral Node Dissection for Stage II, III Lower Rectal Cancer (JCOG0212)
2003-06-01
2015-06-01
Completed
700
A Trial of Chemotherapy Before and After Surgery for Stage II,III Esophageal Squamous Cell Carcinoma
2000-05-01
2009-05-01
Terminated
330
A Trial of Neoadjuvant TS-1 and Cisplatin for Type 4 and Large Type 3 Gastric Cancer
2005-11-01
2015-04-01
Completed
316
Phase III Study of Docetaxel + S-1 vs. S-1 for Advanced Gastric Cancer
2006-03-01
2010-10-01
Completed
628
Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus
2007-07-01
2011-01-01
Completed
25
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Tokyo Medical and Dental University Hospital" #1 sponsor was "Eli Lilly and Company" with 13 trials, followed by "Pfizer" with 8 trials
sponsored, "Hoffmann-La Roche" with 7 trials sponsored, "Janssen Research & Development, LLC" with 7 trials sponsored and "Haruhiko Fukuda"
with 7 trials sponsored. Other sponsors include 50 different institutions and
companies that sponsored additional 36 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Tokyo Medical and Dental University Hospital"
#1 collaborator was "Ministry of Health, Labour and Welfare, Japan" with 6 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "Japan Agency for Medical Research and Development" with 2 trials as a collaborator, "Japan Clinical Oncology Group" with 2 trials as a collaborator and "Japan Lung Cancer Society" with 2 trials as a collaborator. Other collaborators include 7 different institutions and companies that were
collaborators in the rest 15 trials.
Clinical Trials Conditions at Tokyo Medical and Dental University Hospital
According to Clinical.Site data, the most researched conditions in "Tokyo Medical and Dental University Hospital" are
"Ulcerative Colitis" (15 trials), "Crohn's Disease" (11 trials), "Atrial Fibrillation" (4 trials), "Colitis, Ulcerative" (4 trials) and "Primary Immunodeficiency Diseases (PID)" (3 trials). Many other conditions were trialed in "Tokyo Medical and Dental University Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Tokyo Medical and Dental University Hospital
Most popular intervention types in "Tokyo Medical and Dental University Hospital" are "Drug" (75 trials), "Other" (10 trials), "Biological" (8 trials), "Device" (8 trials) and "Procedure" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (30 trials), "Mirikizumab" (7 trials), "Baricitinib" (4 trials), "CP-690,550" (4 trials) and "Filgotinib" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Tokyo Medical and Dental University Hospital
The vast majority of trials in "Tokyo Medical and Dental University Hospital" are
94 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Tokyo Medical and Dental University Hospital
Currently, there are NaN active trials in "Tokyo Medical and Dental University Hospital".
undefined are not yet recruiting,
25 are recruiting,
19 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 40 completed trials in Tokyo Medical and Dental University Hospital,
undefined suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Tokyo Medical and Dental University Hospital, 2 "Phase 1"
clinical trials were conducted, 23 "Phase 2" clinical
trials and 62 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 5 trials that are defined as “Not Applicable".